187 related articles for article (PubMed ID: 12942582)
1. Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women.
Rosser RJ
Cancer; 2003 Sep; 98(5):1102-3; author reply 1103. PubMed ID: 12942582
[No Abstract] [Full Text] [Related]
2. Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women.
Rodrigues NA; Dillon D; Carter D; Parisot N; Haffty BG
Cancer; 2003 Mar; 97(6):1393-403. PubMed ID: 12627502
[TBL] [Abstract][Full Text] [Related]
3. [Use of polymerase chain reaction (PCR) as an additional diagnostic method in gynecologic oncology].
Czerwenka KF; Zeillinger R; Kury F; Manavi M; Speiser P; Peschke M; Steinhart U; Hosmann JW; Kubista E
Gynakol Rundsch; 1991; 31 Suppl 2():378-9. PubMed ID: 1686430
[No Abstract] [Full Text] [Related]
4. [Correlations between receptor state and various clinico-morphological parameters: evaluation of circa 2000 cases of breast tumors].
Lampertico P; Stagni F
Pathologica; 1985; 77(1049):281-97. PubMed ID: 3008068
[No Abstract] [Full Text] [Related]
5. [The effect of transport conditions on biochemically and immunohistochemically determined steroid hormone receptor content in breast cancer].
Remmele W; Schicketanz KH
Pathologe; 1993 Jan; 14(1):21-4. PubMed ID: 8383846
[No Abstract] [Full Text] [Related]
6. [Morphometric correlates of the steroid receptor content in invasive ductal breast cancers].
Mattfeldt T; Neurohr W; Müller A; Klinga K
Verh Dtsch Ges Pathol; 1985; 69():350-5. PubMed ID: 3006385
[No Abstract] [Full Text] [Related]
7. [Cell receptors and proliferation markers in breast cancer].
Czerwenka KF; Schön HJ; Zeillinger R; Kubista E; Spona J
Gynakol Rundsch; 1989; 29 Suppl 2():400-1. PubMed ID: 2558992
[No Abstract] [Full Text] [Related]
8. [Morphologic and morphometric parameters of infiltrating duct carcinoma of the breast and receptor state in fluorescence: correlations in 104 cases (1983 case survey)].
Tunesi G; Anselmi L; Bandelloni R; Gambini C; Reale A; Sementa AR; Bronzini E
Pathologica; 1985; 77(1049):251-8. PubMed ID: 3008066
[No Abstract] [Full Text] [Related]
9. [Ductal carcinoma in situ: steroid receptors and proliferation kinetics].
Ronay G; Sponsel N; Tulusan AH
Pathologe; 1990 Nov; 11(6):327-31. PubMed ID: 1963219
[No Abstract] [Full Text] [Related]
10. [Prognostic factors of breast cancer].
Tang P; Wei B; Yang WJ; Liu YS; Bu H
Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):73-6. PubMed ID: 21426799
[No Abstract] [Full Text] [Related]
11. [Hormone receptor status in breast cancer in comparison with histologic tumor type].
Kasch R; Meissner J; Haack D; Neumann S
Zentralbl Gynakol; 1987; 109(24):1493-6. PubMed ID: 2831683
[TBL] [Abstract][Full Text] [Related]
12. [Inflammatory breast cancers: correlation between anatomopathology and steroid receptor assay].
Mauriac L; Wafflart J; Trojani M; Durand M
Bull Cancer; 1983; 70(3):160-4. PubMed ID: 6309290
[TBL] [Abstract][Full Text] [Related]
13. Breast carcinoma in women 35 years and younger: a pathological study.
Fernandopulle SM; Cher-Siangang P; Tan PH
Pathology; 2006 Jun; 38(3):219-22. PubMed ID: 16753742
[TBL] [Abstract][Full Text] [Related]
14. [Hormonal receptors and breast cancer. Review of the literature and personal experience].
Gallo A; Baldi F; Giannantoni C; Dell'Agli P; Caselli G
Minerva Chir; 1988 Mar; 43(5):429-32. PubMed ID: 2840607
[No Abstract] [Full Text] [Related]
15. [Importance of the study of hormonal receptors in the treatment of breast carcinoma (case report)].
Carli C; Botto A; Podestà AM; Bottino S
Pathologica; 1985; 77(1049):349. PubMed ID: 3008071
[No Abstract] [Full Text] [Related]
16. Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma?
Sullivan PS; Apple SK
Breast J; 2009; 15(2):146-54. PubMed ID: 19292800
[TBL] [Abstract][Full Text] [Related]
17. [Biological features of breast cancer in patients under 35].
Damenia AO; Turkevich EA; Semiglazov VF; Kochetova IA; Gurbanov SS; Bit-Sava EM; Efimenko AV
Vopr Onkol; 2007; 53(6):674-6. PubMed ID: 18416136
[TBL] [Abstract][Full Text] [Related]
18. Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast.
Honma N; Takubo K; Akiyama F; Sawabe M; Arai T; Younes M; Kasumi F; Sakamoto G
Histopathology; 2005 Aug; 47(2):195-201. PubMed ID: 16045781
[TBL] [Abstract][Full Text] [Related]
19. [Estrogen receptors and clinical prognostic factors in breast cancer].
Hernández JL; Lera JM; Fakih A; Gómez Portilla A; Vicente F; Zornoza G
Rev Esp Oncol; 1983; 30(2):179-88. PubMed ID: 6097962
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between histopathological type and biochemical dosage of estradiol and progesterone receptors in women with primary carcinoma of the breast].
Gebrim LH; de Lima GR; dos Santos HB; Guidugli Neto J; Grabert H
Rev Paul Med; 1987; 105(4):195-200. PubMed ID: 3454477
[No Abstract] [Full Text] [Related]
[Next] [New Search]